Myelodysplastic Syndromes News and Research

RSS
Promising results of combination treatment for acute myeloid leukemia to be presented at ASCO 2022

Promising results of combination treatment for acute myeloid leukemia to be presented at ASCO 2022

Risk factors for COVID-19 in patients with hematological malignancies

Risk factors for COVID-19 in patients with hematological malignancies

Discovery may open novel avenues to prevent or treat hematological malignancies

Discovery may open novel avenues to prevent or treat hematological malignancies

Study provides insight into what causes therapy failure in patients with myelodysplastic syndromes

Study provides insight into what causes therapy failure in patients with myelodysplastic syndromes

Optical genome mapping holds potential to become an important component of leukemia diagnostics

Optical genome mapping holds potential to become an important component of leukemia diagnostics

Defective gene in blood cancers could be treated with already available drugs

Defective gene in blood cancers could be treated with already available drugs

Novel therapy found to be safe and well-tolerated in patients with bone marrow cancer

Novel therapy found to be safe and well-tolerated in patients with bone marrow cancer

Investigational combo therapy shows promise in treating TP53 mutant MDS and AML patients

Investigational combo therapy shows promise in treating TP53 mutant MDS and AML patients

Beat AML trial achieves primary endpoint

Beat AML trial achieves primary endpoint

MD Anderson and Astex Pharmaceuticals partner to accelerate clinical evaluation of leukemia therapies

MD Anderson and Astex Pharmaceuticals partner to accelerate clinical evaluation of leukemia therapies

Study identifies impact of gene mutations on severity of myelodysplastic syndrome

Study identifies impact of gene mutations on severity of myelodysplastic syndrome

Research reveals the molecular landscape of myelodysplastic/myeloproliferative neoplasms

Research reveals the molecular landscape of myelodysplastic/myeloproliferative neoplasms

Researchers receive innovative grants to understand the biological underpinnings of blood cancers

Researchers receive innovative grants to understand the biological underpinnings of blood cancers

Newer treatment approaches may reduce risk of therapy-related hematologic cancers

Newer treatment approaches may reduce risk of therapy-related hematologic cancers

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

Kurome secures license to develop novel therapies for chemo-resistant cancer

Kurome secures license to develop novel therapies for chemo-resistant cancer

New clinical trial uses universal natural killer cell approach to treat acute myeloid leukemia

New clinical trial uses universal natural killer cell approach to treat acute myeloid leukemia

New research could lead to 'breakthrough' for myelodysplastic syndrome

New research could lead to 'breakthrough' for myelodysplastic syndrome

Rutgers researchers identify small mutations for AML and MDS through deep DNA sequencing

Rutgers researchers identify small mutations for AML and MDS through deep DNA sequencing

Venetoclax in combination with azacytidine aids therapy for myelodysplastic syndromes

Venetoclax in combination with azacytidine aids therapy for myelodysplastic syndromes